1/ Back from #AANAM and missing the learning?
Enter #ContinuumCase
A 75-yo👩 presents to clinic.
- 1 month ago: monocular blurred vision in L👁️
- C U/S: 70% to 80% ICA stenosis
- On ASA 81 & Atorva 20mg; LDL 132 mg/dL b/f lipid therapy
How do you proceed?
[not her MRA]
3/ Management of a Hot Carotid (or, in this case, a chilled carotid) can get spicy 🌶️!
This is an area in neurology where we (actually!) have trial data, but things get complicated based on the patient's:
⚧️Gender
🔞Age
💊Medical risk factors
⏲️Timing from index ischemic event
4/ First generation trials demonstrated significant benefit for patients with recent symptoms and 70-99% stenosis, and modest benefit for patients with 50-69% stenosis.
But not all populations saw the same degree of benefit!
5/ So for example, in our case several features of this patient make her likely to have a low degree of benefit for revascularization, including:
- Female sex
- Retinal event
- Symptoms > 2 weeks ago
And she did well on continued medical treatment alone.
6/ While it seems that older patients would do better with the less invasive CAS, the reverse is actually true.
Older patients have less complications with CEA and this is the preferred method for a patient like this, should revascularization have been attempted.
7/ In many ways, management of these patients seems straight forward, but there is nuance.
8/ If there is one interview you listen to this month (and why stop at one!?), make it this one: journals.lww.com/continuum/page…
9/ As an aside, I personally have always heparinized patients between index event & revascularization. But @ChaturvediNeuro makes an evidenced-based case for DAPT.
I am now so curious about how many surgeons feel ok about CEA on DAPT!
What’s the practice at your place?
10/ For a comprehensive but approachable review on the approach to large artery atherosclerosis, definitely check out in this month’s @ContinuumAAN's article by @ChaturvediNeuro:
A 67 yo man with a known, active cancer presents to the ED. His wife reports that he has had worsening headaches, forgetfulness, & confusion. Today, he was increasingly sleepy which triggered the presentation.
2/ Neurologic complications in cancer patients are tricky. They can be due to
✨Malignant lesions
✨Systemic complications of disease
✨Paraneoplastic disorders
✨Treatment Side effects
3/ You absolutely must have a systemic approach to these patients. I think the best framework for this is in this review by @holroyd_katie, Dan Rubin and Henrikas Vaitkevicius: pubmed.ncbi.nlm.nih.gov/34619783/
2/ Also @CroninNeuro pointed out that high RoPE (>= 7) and PFO and you should close regardless thus no testing needed for FVL or PT gene mutation.
True! You could throw away all venous testing… closing a PFO in this situation is evidenced based regardless of test outcome.
3/ BUT, TBH, I think I might want to know if I were at potentially higher than average for benefit from closure since no procedure has zero risk...But, has not been looked at in any RCT!
Just another data for personalization, and these tests aren't